Pfizer announced that an early analysis of its COVID‑19 vaccine trial suggested it was 90% effective in preventing the disease. It may begin manufacturing millions of vaccine doses this year. How much credit, if any, do you believe President Donald Trump should receive for the vaccine's possible readiness? Published on November 10, 2020 → Survey conducted on November 10, 2020 on 5675 U.S. adults
